Avanos Medical Inc AVNS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AVNS is a good fit for your portfolio.
News
-
Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall
-
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results
-
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
Trading Information
- Previous Close Price
- $18.95
- Day Range
- $18.70–19.16
- 52-Week Range
- $17.24–31.31
- Bid/Ask
- $0.00 / $24.96
- Market Cap
- $866.79 Mil
- Volume/Avg
- 125,765 / 246,238
Key Statistics
- Price/Earnings (Normalized)
- 16.75
- Price/Sales
- 1.31
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 2.20%
Company Profile
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,771
- Website
- https://www.avanos.com
Comparables
Valuation
|
Metric
|
AVNS
|
PEN
|
MMSI
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.75 | 138.05 | 24.34 |
Price/Book Value | 0.71 | 6.75 | 3.53 |
Price/Sales | 1.31 | 7.62 | 3.40 |
Price/Cash Flow | 17.52 | 45.73 | 19.87 |
Price/Earnings
AVNS
PEN
MMSI
Financial Strength
|
Metric
|
AVNS
|
PEN
|
MMSI
|
|---|---|---|---|
Quick Ratio | 0.98 | 3.25 | 3.81 |
Current Ratio | 2.08 | 6.06 | 5.45 |
Interest Coverage | 0.28 | 42.88 | 8.07 |
Quick Ratio
AVNS
PEN
MMSI
Profitability
|
Metric
|
AVNS
|
PEN
|
MMSI
|
|---|---|---|---|
Return on Assets (Normalized) | 2.78% | 5.67% | 9.43% |
Return on Equity (Normalized) | 3.80% | 7.62% | 14.77% |
Return on Invested Capital (Normalized) | 3.78% | 5.96% | 11.47% |
Return on Assets
AVNS
PEN
MMSI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lyvbrwxq | Nntrxlc | $185.8 Bil | |
SYK
| Stryker Corp | Cvwrdkcgsc | Vvh | $124.7 Bil | |
MDT
| Medtronic PLC | Rxmhkkgt | Yzqqqn | $105.2 Bil | |
BSX
| Boston Scientific Corp | Hfpymrdr | Ygnbdt | $99.0 Bil | |
DXCM
| DexCom Inc | Pdtxqqgm | Fhfm | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Xjqqspwjw | Hhxkqx | $52.3 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vnkjgrsh | Xbvx | $25.0 Bil | |
ALGN
| Align Technology Inc | Xzbwvpyr | Grfqhc | $22.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Wjhqzpt | Ptpsxn | $18.5 Bil | |
PODD
| Insulet Corp | Zhkdgmrsl | Nlcgb | $11.5 Bil |